SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-22-015674
Filing Date
2022-04-26
Accepted
2022-04-26 16:05:41
Documents
4
Period of Report
2022-06-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A kzr-def14a_20220615.htm DEF 14A 704614
2 GRAPHIC g40q5acszrzh000001.jpg GRAPHIC 11483
3 GRAPHIC g40q5acszrzh000002.jpg GRAPHIC 404283
4 GRAPHIC g40q5acszrzh000003.jpg GRAPHIC 223827
  Complete submission text file 0001564590-22-015674.txt   1586532
Mailing Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-822-5600
Kezar Life Sciences, Inc. (Filer) CIK: 0001645666 (see all company filings)

IRS No.: 473366145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38542 | Film No.: 22854314
SIC: 2834 Pharmaceutical Preparations